Is Barrett's Metaplasia the Source of Adenocarcinomas of the Cardia?

Archives of Surgery

Volumn 129, Issue 6, 1994, Pages 609-614

  Clark, Geoffrey W B ^a   Smyrk, Thomas C ^b   Burdiles, Patricio ^a   Hoeft, Sebastian F ^a   Peters, Jeffrey H ^a   Kiyabu, Milton ^a   Hinder, Ronald A ^c   Bremner, Cedric G ^a   Demeester, Tom R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

^c CREIGHTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER LOCALIZATION; CANCER STAGING; CARDIA; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; CARDIA; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; GASTRECTOMY; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HERNIA, HIATAL; HUMAN; LIFE TABLES; MALE; METAPLASIA; MIDDLE AGE; NEOPLASM STAGING; PREVALENCE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0028365812     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1994.01420300051007     Document Type: Article

References (34)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287-1289.
2. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer. 1990;62:440-443.
3. Yang PC, Davis S. Incidence of cancer of the esophagus in the US by histological type. Cancer. 1988;61:612-617.
4. Hesketh PJ, Clapp RW, Doos WG, Spechler SJ. The increasing frequency of adenocarcinoma of the esophagus. Cancer. 1989;64:526-530.
5. Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, DeMeester TR. Barrett's esophagus: comparison of benign and malignant cases. Ann Surg. 1983;198:554-566.
6. Haggit RC, Tryzelaar J, Ellis FH, Colcher H. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol. 1978;70:1-5.
7. Hameeteman W, Tytgat GNJ, Houthoff HJ, VanDerTweel JC. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989; 96:1249-1256.
8. Rogers EL, Goldkin SF, Iseri OA, et al. Adenocarcinoma of the lower esophagus: a disease primarily of white men with Barrett's esophagus. J Clin Gastroenterol. 1986;8:613-618.
9. Levi F, Ollyo JB, La-Vecchia C, Boyle P, Monnier P, Savary M. The consumption of tobacco, alcohol and the risk of adenocarcinoma in Barrett's oesophagus. Int J Cancer. 1990;45:852-854.
10. Iascone C, DeMeester TR, Little AG, Skinner DB. Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg. 1983;118:543-549.
11. Webb JN, Busuttil A. Adenocarcinoma of the oesophagus and of the oesophagogastric junction. Br J Surg. 1978;65:475-479.
12. Kalish RJ, Clancy PE, Orringer MB, Appleman HD. Clinical, epidemiologic and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia. Gastroenterology. 1984;86:461-467.
13. Wang HH, Antonioli DA, Goldman H. Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency. Hum Pathol. 1986;17:482-487.
14. Silverberg E, Lubera J. Cancer statistics. CA Cancer J Clin. 1987;37:2-19.
15. Hamilton SR, Smith RRL, Cameron JL. Prevalence and characteristics of Barrett's esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol. 1988;19:942-948.
16. Lomboy CT, Pera M, Cameron AJ, Carpenter HA, Trastek VF. Adenocarcinoma of the esophagus and esophagogastric junction are both associated with Barrett's epithelium. Gastroenterology. 1992;(suppl)102:A373.
17. Riddell RH, Goldman H. Ranschoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-968.
18. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand. 1965;46:31-49.
19. Skinner DB, Ferguson MK, Soriano A, Little AG, Staszak VM. Selection of operation for esophageal cancer based on staging. Ann Surg. 1986;204:391-401.
20. Attwood SEA, DeMeester TR, Bremner CG, Barlow AP, Hinder RA. Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus. Surgery. 1989;106:764-770.
21. Stein HJ, Barlow AP, DeMeester TR, Hinder RA. Complications of gastroesophageal reflux disease: the role of the lower esophageal sphincter, esophageal acid/alkaline exposure, and duodenogastric reflux. Ann Surg. 1992;216:35-43.
22. Winters C, Spurling TJ, Chobanian SJ, et al. Barrett's esophagus: a prevalent occult complication of gastroesophageal reflux disease. Gastroenterology. 1987; 92:118-124.
23. Cameron AJ, Zinsmeister AR, Ballard DJ, Adan-Carney J. Prevalence of columnar-lined (Barrett's) esophagus: comparison of population-based clinical and autopsy findings. Gastroenterology. 1990;99:918-922.
24. Spechler SJ, Robbins AH, Bloomfield Rubins H, et al. Adenocarcinoma and Barrett's esophagus: an overrated risk? Gastroenterology. 1984;87:927-933.
25. Pellegrini CA, DeMeester TR, Wernley JA, et al. Alkaline gastroesophageal reflux. Am J Surg. 1978;135:177-184.
26. Gotley DC, Morgan AP, Cooper MJ. Bile acid concentrations in the refluxate of patients with reflux esophagitis. Br J Surg. 1988;75:587-590.
27. Champion G, Singh S, Bechi P, Richter JE. Duodenogastric reflux: relationship to esophageal pH and response to omeprazole. Gastroenterology. 1993;104 (suppl):A51.
28. Clark GWB, Smyrk TC, Mirvish SS, et al. The effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol. In press.
29. Pera M, Cardesa A, Bombi JA, Heinrich E, Pera C, Mohr U. Influence of esophagoduodenostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by the subcutaneous injection of 2,6 dimethylnitrosomorpholine. Cancer Res. 1989;49:6803-6808.
30. Attwood SEA, Smyrk TC, DeMeester TR, Mirvish SS, Stein HJ, Hinder RA. Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery. 1992;111:503-510.
31. Clark GWB, Smyrk TC, Hoeft SF, et al. Is the length of Barrett's mucosa related to the prevalence of complications and adenocarcinoma in Barrett's esophagus? Gastroenterology. 1993;104(suppl):A393.
32. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci. 1992;37:137-143.
33. McArdle JE, Lewin KJ, Randall G, Weinstein W. Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum Pathol. 1992;23:479-482.
34. Costantini M, Crookes PF, Bremner RM, et al. Value of physiologic assessment of foregut symptoms in a surgical practice. Surgery. 1993;114:780-787.